Daniel Powell has over 25 years of experience delivering technical solutions across multiple industries. In 2006, Mr. Powell found his true passion in medical devices, specifically neurostimulation, and has since launched multiple products in the space, including Deep Brain Stimulation for movement disorders and Vagus Nerve Stimulation for Epilepsy. Mr. Powell co-founded and serves as CEO of Spark Biomedical, the developer of the FDA-cleared Sparrow Ascent; a novel, wearable neurostimulation solution to address opioid withdrawal and addiction for adults. Under Mr. Powell's leadership, Spark continues to advance the science of wearable neurostimulation and is developing a solution for Neonatal Opioid Withdrawal Syndrome - addressing the most vulnerable victims of the opioid epidemic, newborn babies.